Robert Comis
Hematology & Oncology · Philadelphia, PANPI 1457414427
Payments from drug & device makers
What this record shows
That places this record below the midpoint for hematology & oncology clinicians in PA, where the typical reported total is $1,277.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$972,218in research payments, 2019–2025
Across 3 payments — averaging $324,073 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$861K
- Eli Lilly$64K
- Lilly USA, LLC$47K
How this compares
$0 in reported general payments places this provider in the 0th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Philadelphia
- Henry FungPhiladelphia$730K
- Charu AggarwalPhiladelphia$541K
- Corey LangerPhiladelphia$492K
- Ankur ParikhPhiladelphia$329K
- Catherine LaiPhiladelphia$281K
- Stephen SchusterPhiladelphia$218K
- Keith PratzPhiladelphia$173K
- David PorterPhiladelphia$140K
- Adam BinderPhiladelphia$136K
- Marcela MausPhiladelphia$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.